Salome Adam

Salome Adam is a Senior Research Scientist at AstraZeneca, where they focus on target validation and arrayed CRISPR screening. They completed a PhD in Biology at Université Pierre et Marie Curie, studying histone dynamics at sites of DNA damage, and earned a Master's degree in Cell/Cellular and Molecular Biology from University Paris VI / ENS Cachan with first class honors. Previously, Salome was a Postdoctoral Research Fellow at Mount Sinai Hospital, where they utilized CRISPR/Cas9 screens to identify genetic vulnerabilities in BRCA-mutated cells, and they were a PhD student at Institut Curie.